A Randomised Controlled Phase II Trial of the Combination of XELOX with Thalidomide for the First-line Treatment of Metastatic Colorectal Cancer

A Randomised Controlled Phase II Trial of the Combination of XELOX with Thalidomide for the First-line Treatment of Metastatic Colorectal Cancer

<b>Objective</b> To evaluate the efficacy and safety of the combination of XELOX regimen (oxaliplatin plus capecitabine) with thalidomide for the first-line treatment of metastatic colorectal cancer (MCRC).<br><b>Methods</b> All of the 89 patients with MCRC who fulfille...

Full description

Bibliographic Details
Main Authors: Jing Lv, Ning Liu, Ke-wei Liu, Ai-ping Ding, Hao Wang, Wen-sheng Qiu
Format: Article
Language:English
Published: China Anti-Cancer Association 2012-06-01
Series:Cancer Biology & Medicine
Subjects:
colorectal neoplasm
thalidomide
oxaliplatin
capecitabine
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/16

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/16

Similar Items